As the spread of Coronavirus (COVID-19) persists throughout the global community, Philips is steadfast in its commitment to support health systems and healthcare professionals who entrust us to help them care for their patients. Philips solutions include invasive and noninvasive ventilation ranging from mid- to high-acuity, oxygen therapy, CPAP therapy, nebulizers, patient monitoring, and medical consumables that can help health systems and clinicians as they navigate this complex and dynamic environment.
Let us know if you have solutions that can be launched into the market as soon as possible, ranging from supplier offers and product modifications to new solution opportunities. We are also interested in opportunities to provide advanced nebulizer systems in support of pharmaceutical drug development programs, including aerosol lab testing support throughout the clinical trial phases, and commercial drug approval and launch.
Please register to access our COVID challenge and share your innovation or opportunity. All entries will be reviewed by Philips. We look forward to collaborating with you!